From Lab Bench to Bedside: Tracking the Accelerated Clinical Trials...

bir ses eklendi Health

2025-11-21 06:18:37 -

From Lab Bench to Bedside: Tracking the Accelerated Clinical Trials of Gene Editing Therapies for Monogenic and Rare Blood Disorders

While CRISPR-Cas9 is celebrated for its ability to cut and replace DNA segments, the limitations associated with creating double-strand breaks have catalyzed the emergence of **next-generation editing technologies** that promise greater precision and safety. **Base editing** and **prime editing** are two such innovations rapidly gaining commercial traction. Base editing allows for the precise...

0 Yorumlar 0 hisse senetleri 921 Views 0 önizleme